JAC Advance Access published online on November 1, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf219
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original Paper
1 INSERM EMI-0212, Faculté de
Médecine Necker-Enfants Malades, 156 rue de Vaugirard,
75730 Paris, France
* Corresponding author. E-mail: matysiak{at}necker.fr.
Received 6 December 2001
; revised 15 August 2002
; accepted 22 August 2002
The mode of absorption of amoxicillin and clarithromycin,
two antibiotics used in the treatment of Helicobacter
pylori infection, has not been completely elucidated. The aims
of this study were to investigate the passage of these antibiotics
across normal and infected epithelium and to measure their accumulation
in HT29-19A or Caco2 epithelial cell monolayers. In non-infected cultures,
basal-to-apical fluxes were significantly higher than apical-to-basal
fluxes for both antibiotics, but this difference disappeared in
monolayers infected with H. pylori. In 24 h studies, clarithromycin,
but not amoxicillin, showed rapid intracellular accumulation. No
difference was found between the transepithelial passage of amoxicillin
across the HT29-19A and Caco2 monolayers.
Keywords: Helicobacter pylori, amoxicillin,
clarithromycin, Ussing chamber, absorption
In vitro transfer of clarithromycin
and amoxicillin across the epithelial barrier: effect of Helicobacter
pylori
2 Sanofi-Synthélabo, 82
avenue Raspail, 94255 Gentilly Cedex, France
3 Laboratoire de Bactériologie,
Université Victor Segalen Bordeaux 2, 146 rue Léo
Saignat, 33076 Bordeaux Cedex, France
![]()
CiteULike
Connotea
Del.icio.us What's this?